GDF-8 (Myostatin)

No completed human trials extracted for GDF-8 (Myostatin). Animal-model evidence carries the indication cards below.

Data last updated

ClinicalResearchDepthClinicalResearchEfficacyno dataClinicalResearchSideEffectsno dataAnecdotalEfficacyno dataAnecdotalSideEffectsno dataPrice0.41.0

Measured on 2 of 6 axes

Research Evidence

Evidence shape

No completed human trials extracted for GDF-8 (Myostatin). Animal-model evidence carries the indication cards below.

Depthhow much
0 registered trials
Breadthhow many areas
1 indication mapped
1 animal-only
Qualityhow rigorous
No completed trials
Breadth and depth16 rows captured
Human
direct clinical signal
0
Animal
translational support
12
In vitro
mechanistic support
4
HighMediumLow

Anecdotal efficacy

Community efficacy aggregate not available or did not pass volume floor

GDF-8 (Myostatin) side effects

Clinical research side effects

Clinical safety table not projected yet.

Anecdotal side effects

Symptom-relevant clinical or community evidence has not been captured for this peptide yet.

1
--
10 mg
$449.90
$44.99/mg
2
GB
1 mg
$56.38
$56.38/mg
3
US
1 mg
$99.00
$99/mg
4
--
2 mg
$199.00
$99.5/mg
5
GB
1 mg
$100.54
$100.54/mg
6
--
1 mg
$105.99
$105.99/mg

price offers can be sorted by column

1-6 of 14

GDF-8 (MYOSTATIN) dosing & protocol

How GDF-8 (MYOSTATIN) is dosed across research, clinician, and community sources — each evidence tier kept separate so the dose range, frequency, timing, and cycling stay visible without flattening different levels of evidence.

Research trials
Published clinical-trial protocols
Typical dose
0
10 mg
20 mg
30 mg
40 mg
no dose captured for this tier yet

No structured protocol details captured for this tier yet.

Clinician practice
Doctor & published-protocol guidance · n = 1
Typical dose
20 mg
typical
0
10 mg
20 mg
30 mg
40 mg
across 1 dosed source · darker = more agree
By reported cadence
Weekly20 mg · n=1
Frequency
weekly
Route
subQ

Clinician protocols dose 20 mg weekly subQ (1 source).

1 source
Anecdotal
Community-reported real-world use
Typical dose
0
10 mg
20 mg
30 mg
40 mg
no dose captured for this tier yet

No structured protocol details captured for this tier yet.